BioSpace News Archive

Policy

Insulet to Pay $19.5M to End Investor Lawsuit

The lawsuit alleged that Insulet misrepresented the success of its OmniPod Eros roll-out in 2013.

February 12, 2018
·
1 min read
Veryan’s Stent Meets Safety, Efficacy Endpoints After One Year

The device, which is shaped to mimic the natural geometry of human vasculature, compared favorably with drug-coated balloons and stents.

February 12, 2018
·
1 min read
Scottish Medtech Vascutek Gets £33M Investment

The company plans to build two new cleanrooms and a sterilisation suite at its manufacturing base at Inchinnan.

February 12, 2018
·
1 min read
Business

Week in Review: Tsinghua University Invests $276M in Cambridge UK Biohub

Beijing’s Tsinghua University will invest $276M in a JV to build a new biohub in the UK’s Cambridge Science Park.

February 12, 2018
·
1 min read
Beijing InnoCare Pharma Raises $55M in Vivo-led Round

InnoCare is developing a portfolio of novel drugs for cancer and autoimmune diseases, using a combination of in-licensing and internal research.

February 12, 2018
·
1 min read
Policy

Catalyst Pharmaceuticals Announces Plans to Resubmit New Drug Application for Firdapse

Resubmission of NDA for Firdapse on schedule for end of the first quarter.

February 12, 2018
·
6 min read
FDA

Vertex Scores FDA Nod for CF Combo Drug, Sets $292,000 Price Tag

The FDA approved Vertex’s Symdeko for cystic fibrosis in patients ages 12 and older with two copies of the F508del mutation.

February 12, 2018
·
3 min read
·
Mark Terry